User profiles for Cécile Tromeur
Cecile TromeurVerified email at chu-brest.fr Cited by 2433 |
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open …
…, O Sitbon, F Parent, R Trésorier, C Tromeur… - The Lancet …, 2022 - thelancet.com
Background Riociguat and balloon pulmonary angioplasty (BPA) are treatment options for
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …
inoperable chronic thromboembolic pulmonary hypertension (CTEPH). However, randomised …
Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension
…, O Sanchez, A Seferian, C Tromeur… - American journal of …, 2021 - atsjournals.org
Rationale: The relationship between the initial treatment strategy and survival in pulmonary
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …
arterial hypertension (PAH) remains uncertain. Objectives: To evaluate the long-term survival …
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an …
…, C Schweizer, H van der Straaten, C Tromeur… - The Lancet, 2022 - thelancet.com
Background Pregnancy-related venous thromboembolism is a leading cause of maternal
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
morbidity and mortality, and thromboprophylaxis is indicated in pregnant and post-partum …
Current incidence of venous thromboembolism and comparison with 1998: a community-based study in Western France
A Delluc, C Tromeur, F Le Ven… - Thrombosis and …, 2016 - thieme-connect.com
In 1998 we estimated the incidence of venous thromboembolism (VTE) to be 1.8/1,000 per
year. The aim of this study was to compare current VTE incidence to that observed in 1998. …
year. The aim of this study was to compare current VTE incidence to that observed in 1998. …
Prevalence of pulmonary embolism among patients with COPD hospitalized with acutely worsening respiratory symptoms
…, C Hoffmann, L Bressollette, M Nonent, C Tromeur… - Jama, 2021 - jamanetwork.com
Importance The prevalence of pulmonary embolism in patients with chronic obstructive
pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain. …
pulmonary disease (COPD) and acutely worsening respiratory symptoms remains uncertain. …
Portopulmonary hypertension in the current era of pulmonary hypertension management
…, S Renard, D Horeau-Langlard, C Tromeur… - Journal of …, 2020 - Elsevier
Background & Aims Long-term outcomes in portopulmonary hypertension (PoPH) are poorly
studied in the current era of pulmonary hypertension management. We analysed the effect …
studied in the current era of pulmonary hypertension management. We analysed the effect …
[HTML][HTML] Computed tomography pulmonary angiography versus ventilation-perfusion lung scanning for diagnosing pulmonary embolism during pregnancy: a …
C Tromeur, LM van der Pol, PY Le Roux… - …, 2019 - ncbi.nlm.nih.gov
Differences between computed tomography pulmonary angiography and ventilation-perfusion
lung scanning in pregnant patients with suspected acute pulmonary embolism are not well…
lung scanning in pregnant patients with suspected acute pulmonary embolism are not well…
Safety and efficacy of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis and carrying a telomere-related gene mutation
…, B Bondue, P Bonniaud, C Tromeur… - European …, 2021 - Eur Respiratory Soc
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive and deadly interstitial lung disease
(ILD). Over the past decade, familial occurrence of IPF led to the identification of genetic …
(ILD). Over the past decade, familial occurrence of IPF led to the identification of genetic …
Serum and pulmonary uric acid in pulmonary arterial hypertension
Previous studies have suggested an association between uric acid (UA) and the severity of
pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease …
pulmonary arterial hypertension (PAH), but it is unknown whether UA contributes to disease …
Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID‐19 patients
…, E L'HER, S ANSART, C TROMEUR… - Journal of Medical …, 2021 - Wiley Online Library
Little is known on the association between clinical factors and coronavirus disease 2019 (COVID‐19)
more than 15 days after diagnosis. We conducted a multicentric prospective cohort …
more than 15 days after diagnosis. We conducted a multicentric prospective cohort …